Active Ingredient: RIBOCICLIB SUCCINATE
Proprietary Name: KISQALI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209092
Product Number: 001
Approval Date: Mar 13, 2017
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
